How calcium signaling affects the clearance of harmful proteins in Alzheimer's disease
Regulation of Neuronal Clearance Pathways via Nuclear Calcium Signaling in Alzheimer's Disease
This study is looking at how problems with calcium signals in brain cells might cause harmful proteins to build up in Alzheimer's disease, and it hopes to find new ways to help keep brain cells healthy, which could lead to better treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers the State Univ of Nj Newark NIH-funded |
| Lab location | 1 site (Newark, United States) |
| Project ID | NIH-10624820 on NIH RePORTER |
What this research studies
This research investigates how disruptions in calcium signaling within neurons may lead to the accumulation of toxic proteins associated with Alzheimer's disease. By focusing on the role of nuclear calcium levels and their impact on the autolysosomal system, the study aims to uncover mechanisms that contribute to neurodegeneration. The researchers will explore how specific genetic mutations related to Alzheimer's affect these processes and may identify new pathways for promoting neuronal health. Patients may benefit from insights that could lead to novel therapeutic strategies targeting these pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with Alzheimer's disease or those at risk due to genetic factors.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance the clearance of neurotoxic proteins in Alzheimer's patients, potentially slowing disease progression.
How similar studies have performed: Previous studies have shown promising results in targeting cellular clearance mechanisms in neurodegenerative diseases, suggesting that this approach may yield beneficial outcomes.
Where this research is happening
Newark, United States
- Rutgers the State Univ of Nj Newark — Newark, United States (Active)
Researchers
- Principal investigator: Friedman, Wilma J — Rutgers the State Univ of Nj Newark
- Study coordinator: Friedman, Wilma J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.